Eurofins Lancaster Labs' published articles from 2010

Perspectives on Method Validation II: Validation is a multistep process with USP regulatory guidelines at each step
Pharmaceutical Formulation Quality, February/March 2010

Authors:
Heather Bridwell - Group Leader/Chemist
Jennifer Roark - Group Leader/Chemist
Thomas Lehman, PhD - Manager of Method Development

Analytical Strategies for Monitoring Residual Impurities -
Best methods to monitor product-related impurities throughout the production process.
Biopharm International, January 2010

Jon S. Kauffman, Ph.D., Director of Biopharmaceutical Services and Analytical Method Development / Validation

Perspectives on Method Validation I: Importance of adequate method validation
Pharmaceutical Formulation Quality, December/January 2010

Authors:
Heather Bridwell - Group Leader/Chemist
Vikas Dhingra, PhD - Group Leader/Biochemist
Daniel Peckman, MS - Group Leader/Biochemist
Jennifer Roark - Group Leader/Chemist
Thomas Lehman, PhD - Manager of Method Development

Do you have the workload but not the workforce?
Life Science Leader, January 2010

Beth DiPaolo
Vice President, Professional Scientific Staffing

LabAccess.com